ATHENS, Greece, March 06, 2026 (GLOBE NEWSWIRE) — Star Bulk Carriers Corp. (the “Company” or “Star Bulk”) (NASDAQ: SBLK), today announced it has entered into a conditional Sale and Purchase Agreement (the “SPA”) to acquire sixteen vessels from Diana Shipping Inc. (“Diana”, NYSE: DSX), subject to Diana successfully acquiring all issued and outstanding shares of Genco Shipping & Trading Ltd. (“Genco”, NYSE:GNK), not already owned by Diana. The aggregate purchase price for the sixteen-vessel acquisition is $470.5 million in cash (“Purchase Price”). The SPA is subject to (i) an agreement being entered between Diana and Genco and successfully being consummated and (ii) customary conditions to S&P transactions. The sixteen vessels that SBLK has agreed to acquire include one Newcastlemax, six Capesize...

Revised Offer of $23.50 Per Share Represents 31% Premium Over Undisturbed Closing Price Prior to Initial Offer Receives Fully Underwritten Commitment for $1.433 Billion in Financing Arranged by DNB Carnegie and Nordea, and Including Other Leading International Banks Star Bulk Enters into Definitive Agreement with Diana to Acquire 16 Genco Vessels for $470.5 Million Calls Upon Genco Board to Immediately Engage in Good Faith Negotiations to Reach Definitive Agreement ATHENS, Greece, March 06, 2026 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX) (“Diana” or the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, that owns approximately 14.8% of the outstanding shares of common stock of Genco Shipping & Trading Limited (NYSE: GNK) (“Genco”), today announced that...

Acquisition to further financial inclusion through integrated digital financial services ecosystem Dubai, New York and Karachi – March 6, 2026 – VEON Ltd. (Nasdaq: VEON, “VEON”), a global digital operator, today announced that its subsidiary Jazz International Holding Limited (“JIH”) has entered into a definitive agreement to acquire a controlling stake in TPL Insurance Limited (“TPL Insurance”), a publicly listed insurance firm in Pakistan. The transaction, which marks a new milestone for VEON’s growing digital financial services portfolio in one of its most dynamic growth markets, is expected to close in mid-2026, subject to regulatory approvals. TPL Insurance, a digital-first insurance provider in Pakistan, offers auto, health, fire and property insurance products through its well-established distribution capabilities, and holds a general...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IDOX PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: IDOX PLC AS AN ASSOCIATE OF THE CANACCORD...

ROBERTET INVESTS IN AETHERA BIOTECH,A EUROPEAN PIONEER IN ACTIVE COSMETIC INGREDIENTSEntering plant-based biotechnologies to advance Robertet’s “Augmented Naturality” strategy Strengthening Robertet’s position in cosmetic active ingredients Boosting long-term growth through a unique range of cosmetic ingredients Aethera will benefit from Robertet’s global networks of clients and commercial capabilitiesGrasse, March 5th, 2026 – Robertet, a world leader in natural raw materials for fragrances, flavors, and active ingredients announces the expansion of its partnership with Aethera Biotech through a strategic investment. This joint venture creates synergies between two family-owned groups sharing common values and a long-term vision. It combines Aethera Biotech’s advanced platform, proprietary intellectual property, production capabilities...

CINCINNATI, March 05, 2026 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT; TSX: QIPT)‎, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, announces that the Supreme Court of British Columbia issued a final order today in connection with the previously announced plan of arrangement under the Business Corporations Act (British Columbia) (the “Arrangement”) pursuant to which affiliates of Kingswood Capital Management, L.P. and Forager Capital Management, LLC will acquire all of the issued and outstanding common shares of the Company (each, a “Share”) for cash consideration of US$3.65 per Share. The final order was the final substantive court approval required prior to the closing of the Arrangement. Assuming all other terms and conditions to the Arrangement are satisfied,...

WEST ORANGE, N.J., March 05, 2026 (GLOBE NEWSWIRE) — Bel Fuse Inc.® (Nasdaq: BELFA and BELFB) (“Bel” or “the Company”), a leading global manufacturer of products that power, protect and connect electronic circuits, is pleased to announce the acquisition of dataMate®, a leading solutions provider of advanced ethernet and broadband technologies, from Methode Electronics Inc.® Bel acquired dataMate for $16 million, including $1 million of deferred consideration. With annual sales of approximately $18 million and operating margins in line with Bel’s corporate averages, the dataMate acquisition is expected to be immediately accretive to Bel’s financials. This transaction expands Bel’s portfolio and positions the Company for accelerated growth in high-demand markets, including networking, data centers, industrial automation, smart...

WARREN, N.J., March 05, 2026 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that it has entered into a signed, non-exclusive, non-binding Letter of Intent (“LoI”) to evaluate a potential transaction with Apozeal Pharmaceutical Inc. (“Apozeal”), a pharmaceutical company focused on the development and manufacturing of high-quality, cost-effective medicines. The proposed transaction represents a strategic step in advancing Tevogen Generics, established to support domestic pharmaceutical manufacturing and enhance affordability and national supply chain resilience. If consummated, the potential acquisition of Apozeal could provide Tevogen with an established generics platform, including:11 FDA-approved Abbreviated New Drug Application (ANDA) products for the U.S. market Multiple...

AUSTIN, Texas, March 05, 2026 (GLOBE NEWSWIRE) — via IBN – Suntex Enterprises, Inc. (OTC: SNTX) today announced that it has executed a Letter of Intent (LOI) to acquire Deep South Electrical Contractors and GoldenEra Development, two operating subsidiaries currently held by Golden Triangle Ventures, Inc. The agreement outlines Suntex’s intent to bring both operating businesses under the Suntex corporate structure, further expanding the Company’s operating footprint across infrastructure, construction services, and development operations. Deep South Electrical Contractors is an active commercial and industrial electrical contractor supporting large-scale infrastructure and technology-driven facilities. GoldenEra Development provides construction management and development services tied to commercial and industrial projects. Both...

ORLANDO, Fla., March 05, 2026 (GLOBE NEWSWIRE) — Exousia Pro, Inc. (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery systems, is pleased to announce several pivotal corporate milestones aimed at enhancing shareholder value and expanding the company’s commercial footprint. Major Capital Structure Optimization Exousia Pro has successfully completed the cancellation of derivative securities convertible into 47 million shares of Common Stock. This substantial reduction was achieved through a strategic mediation and exchange agreement. In lieu of a prolonged legal dispute, the Company exchanged 2 million shares of LMMY for the cancellation of Series B Preferred shares (which were convertible into the 47 million common shares). As part of this transaction, Ludwig Enterprises, Inc....